Anbio Biotechnology Limited NNNN
$16.48
▼ -5.17% 24H
About
Anbio Biotechnology Limited is a healthcare technology company specializing in the development and manufacturing of advanced in vitro diagnostic (IVD) products. Established in 2021, the company’s primary focus is to revolutionize diagnostics by delivering innovative solutions that support personalized and decentralized…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Instruments & Supplies
CountryGermany
Employees27
TickerNNNN
Statistics
Market Cap$723.1M
Revenue (TTM)$8.6M
Net Income$6.4M
Net Margin74.1%
EPS$0.15
P/E109.60
P/S83.45
P/B23.93
EV/EBITDA134.47
ROE27.0%
Dividend Yield—
Price$16.48
Data: Twelve Data · Revenue = mcap / P/S